These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25097078)

  • 1. Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
    Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
    Med Oncol; 2014 Sep; 31(9):145. PubMed ID: 25097078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer.
    Hou T; Liang D; Xu L; Huang X; Huang Y; Zhang Y
    Gynecol Oncol; 2013 Jul; 130(1):181-7. PubMed ID: 23603371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes.
    Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2011 Feb; 125(3):715-27. PubMed ID: 20369284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
    Hao L; Zhang C; Qiu Y; Wang L; Luo Y; Jin M; Zhang Y; Guo TB; Matsushima K; Zhang Y
    Cancer Lett; 2007 Aug; 253(1):34-42. PubMed ID: 17306924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
    Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
    Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Downregulation of Duffy antigen receptor for chemokine (DARC) is associated with lymph node metastasis in human breast cancer].
    Ou ZL; Wang J; Hou YF; Luo JM; Shen ZZ; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):586-9. PubMed ID: 17236552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
    Lu CL; Ji Y; Ge D; Guo J; Ding JY
    Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
    Zheng SQ; Huang RQ; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
    Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
    Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer.
    Zhu Z; Sun Z; Wang Z; Guo P; Zheng X; Xu H
    J Surg Res; 2013 Jul; 183(1):177-83. PubMed ID: 23462454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
    Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
    BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer.
    Yang C; Yu KD; Xu WH; Chen AX; Fan L; Ou ZL; Shao ZM
    PLoS One; 2013; 8(11):e78901. PubMed ID: 24260134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization.
    Takatsuka S; Sekiguchi A; Tokunaga M; Fujimoto A; Chiba J
    J Pharmacol Toxicol Methods; 2011; 63(3):250-7. PubMed ID: 21184834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.
    Harata-Lee Y; Turvey ME; Brazzatti JA; Gregor CE; Brown MP; Smyth MJ; Comerford I; McColl SR
    Immunol Cell Biol; 2014 Nov; 92(10):815-24. PubMed ID: 25027038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
    Wang Q; Diao X; Sun J; Chen Z
    Urol Oncol; 2013 Apr; 31(3):312-7. PubMed ID: 21367627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical value of tumor FDG uptake for predicting axillary lymph node metastasis in breast cancer with clinically negative axillary lymph nodes.
    Seok JW; Kim Y; An YS; Kim BS
    Ann Nucl Med; 2013 Jul; 27(6):546-53. PubMed ID: 23543486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
    Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
    Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
    Jobim FC; Xavier NL; Uchoa DM; Cruz DB; Saciloto M; Chemello N; Schwartsmann G
    Braz J Med Biol Res; 2009 Oct; 42(10):979-87. PubMed ID: 19787153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
    Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
    Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.